Ind-Swift Laboratories Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported sales was INR 3,042.46 million compared to INR 3,066.47 million a year ago. Revenue was INR 3,144.53 million compared to INR 3,278.59 million a year ago. Net loss was INR 240.85 million compared to INR 614.53 million a year ago. Basic loss per share from continuing operations was INR 4.08 compared to INR 10.4 a year ago. Diluted loss per share from continuing operations was INR 4.08 compared to INR 10.4 a year ago.
For the full year, sales was INR 12,073.1 million compared to INR 10,387.34 million a year ago. Revenue was INR 12,408.1 million compared to INR 10,822.29 million a year ago. Net income was INR 475.97 million compared to net loss of INR 21.49 million a year ago. Basic earnings per share from continuing operations was INR 8.06 compared to basic loss per share from continuing operations of INR 0.36 a year ago. Diluted earnings per share from continuing operations was INR 8.06 compared to diluted loss per share from continuing operations of INR 0.36 a year ago.